188 related articles for article (PubMed ID: 29293475)
1. Pharmacokinetics and pharmacodynamics of antibiotics in central nervous system infections.
Nau R; Seele J; Djukic M; Eiffert H
Curr Opin Infect Dis; 2018 Feb; 31(1):57-68. PubMed ID: 29293475
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections.
Nau R; Sörgel F; Prange HW
Clin Pharmacokinet; 1998 Sep; 35(3):223-46. PubMed ID: 9784935
[TBL] [Abstract][Full Text] [Related]
3. [Antibiotic diffusion to central nervous system].
Cabrera-Maqueda JM; Fuentes Rumí L; Valero López G; Baidez Guerrero AE; García Molina E; Díaz Pérez J; García-Vázquez E
Rev Esp Quimioter; 2018 Feb; 31(1):1-12. PubMed ID: 29390599
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.
Sullins AK; Abdel-Rahman SM
Paediatr Drugs; 2013 Apr; 15(2):93-117. PubMed ID: 23529866
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review.
Khawcharoenporn T; Apisarnthanarak A; Mundy LM
Clin Microbiol Infect; 2010 Jul; 16(7):888-94. PubMed ID: 19686281
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal Antibacterial and Antifungal Therapies.
Nau R; Blei C; Eiffert H
Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32349999
[TBL] [Abstract][Full Text] [Related]
7. Intra-cerebrospinal fluid antibiotics to treat central nervous system infections: A review and update.
Mrowczynski OD; Langan ST; Rizk EB
Clin Neurol Neurosurg; 2018 Jul; 170():140-158. PubMed ID: 29800828
[TBL] [Abstract][Full Text] [Related]
8. Intrathecal or intraventricular administration of colistin, vancomycin and amikacin for central nervous system infections in neurosurgical patients in an intensive care unit.
Tsimogianni A; Alexandropoulos P; Chantziara V; Vassi A; Micha G; Lagiou F; Chinou E; Michaloudis G; Georgiou S
Int J Antimicrob Agents; 2017 Mar; 49(3):389-390. PubMed ID: 28163138
[No Abstract] [Full Text] [Related]
9. Central nervous system infections and antimicrobial resistance: an evolving challenge.
Nau R; Sörgel F; Eiffert H
Curr Opin Neurol; 2021 Jun; 34(3):456-467. PubMed ID: 33767092
[TBL] [Abstract][Full Text] [Related]
10. Intraventricular or intrathecal colistin for the treatment of central nervous system infections caused by multidrug-resistant Gram-negative bacteria.
Imberti R; Iotti GA; Regazzi M
Expert Rev Anti Infect Ther; 2014 Apr; 12(4):471-8. PubMed ID: 24597575
[TBL] [Abstract][Full Text] [Related]
11. Population Pharmacokinetics of Combined Intravenous and Local Intrathecal Administration of Meropenem in Aneurysm Patients with Suspected Intracranial Infections After Craniotomy.
Li X; Sun S; Wang Q; Zhao Z
Eur J Drug Metab Pharmacokinet; 2018 Feb; 43(1):45-53. PubMed ID: 28616823
[TBL] [Abstract][Full Text] [Related]
12. Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections.
Luque S; Grau S; Alvarez-Lerma F; Ferrández O; Campillo N; Horcajada JP; Basas M; Lipman J; Roberts JA
Int J Antimicrob Agents; 2014 Nov; 44(5):409-15. PubMed ID: 25216547
[TBL] [Abstract][Full Text] [Related]
13. Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review.
Ng J; Gosbell IB; Kelly JA; Boyle MJ; Ferguson JK
J Antimicrob Chemother; 2006 Nov; 58(5):1078-81. PubMed ID: 16916866
[TBL] [Abstract][Full Text] [Related]
14. Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.
Nau R; Sörgel F; Eiffert H
Clin Microbiol Rev; 2010 Oct; 23(4):858-83. PubMed ID: 20930076
[TBL] [Abstract][Full Text] [Related]
15. The penetration of anti-infectives into the central nervous system.
Kearney BP; Aweeka FT
Neurol Clin; 1999 Nov; 17(4):883-900. PubMed ID: 10517933
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial use in central nervous system infections.
Ciummo F; Srinivas P; Biedny J
Curr Opin Infect Dis; 2021 Jun; 34(3):255-263. PubMed ID: 33741793
[TBL] [Abstract][Full Text] [Related]
17. [Combined intravenous and intrathecal vancomycin in treatment of patients with intracranial infections after craniotomy].
Bao Y; Qiu B; Zeng H; Mo Y; Zhang N; Qi S
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Feb; 28(2):169-72. PubMed ID: 26911951
[TBL] [Abstract][Full Text] [Related]
18. [Antibiotics in the treatment of bacterial infections of the central nervous system].
Doder R; Canak G; Vukadinov J; Turkulov V; Sević S
Med Pregl; 2010; 63 Suppl 1():22-6. PubMed ID: 21438200
[TBL] [Abstract][Full Text] [Related]
19. The importance of pharmacokinetics and pharmacodynamics for effective treatment of infections.
Mattie H
Clin Investig; 1993 Jun; 71(6):480-2. PubMed ID: 8394759
[No Abstract] [Full Text] [Related]
20. Intracellular Pharmacokinetics of Antibacterials and Their Clinical Implications.
Pea F
Clin Pharmacokinet; 2018 Feb; 57(2):177-189. PubMed ID: 28639230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
